Medicine and Dentistry
Sertraline
100%
Cost-Effectiveness Analysis
100%
Placebo
100%
Mirtazapine
100%
Antidepressant
75%
Diabetes
50%
Randomized Controlled Trial
50%
Preschooler
50%
Mild Cognitive Impairment
50%
Intellectual Disability
50%
Base
33%
Diabetes Mellitus
30%
Alzheimer's Disease
26%
Cornell Scale for Depression in Dementia
25%
Adverse Event
25%
Quality of Life
16%
Child Parent Relation
16%
Child Behavior
16%
Self Report
10%
Cognitive Defect
10%
Hazard Ratio
10%
General Practitioner
10%
Diseases
10%
Primary Health Care
10%
Technology Assessment
8%
Drug Therapy
8%
Treatment of Depression
8%
Clinical Trials Unit
8%
Health Technology
8%
Linear Regression Analysis
8%
Psychogeriatrics
8%
Pharmacology, Toxicology and Pharmaceutical Science
Mirtazapine
100%
Sertraline
100%
Placebo
83%
Alzheimer's Disease
60%
Antidepressant
54%
Randomized Controlled Trial
50%
Mild Cognitive Impairment
50%
Tolerability
50%
Side Effect
40%
Diabetes Mellitus
30%
Base
25%
Diseases
20%
Cognitive Defect
10%
Treatment Group
10%
Nursing and Health Professions
Cost Effectiveness Analysis
50%
Sertraline
50%
Mirtazapine
50%
Mild Cognitive Impairment
50%
Placebo
33%
Diabetes Mellitus
30%
Hazard Ratio
10%
Self Report
10%
Alzheimer's Disease
10%
Cognitive Defect
10%
Diseases
10%
General Practitioner
10%
Primary Medical Care
10%
